1. Journal searcher
  2. Top 15 journals in Oncology
  3. Oncotarget
Default: Oncotarget

ISSN:

Journal Home

Journal Guideline

Oncotarget Q2 Unclaimed

Impact Journals LLC United States
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Oncotarget is a journal indexed in SJR in Oncology with an H index of 165. It has an SJR impact factor of 0,801 and it has a best quartile of Q2. It has an SJR impact factor of 0,801.

Oncotarget focuses its scope in these topics and keywords: cancer, cell, cells, breast, human, tumor, expression, inhibition, protein, lung, ...

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

WOS
Categories: Oncology (Q2)
Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

Oncotarget

0,801

SJR Impact factor

165

H Index

138

Total Docs (Last Year)

1363

Total Docs (3 years)

5102

Total Refs

3369

Total Cites (3 years)

1218

Citable Docs (3 years)

2.54

Cites/Doc (2 years)

36.97

Ref/Doc

Comments

No comments ... Be the first to comment!
User post comment
* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Frontiers in Oncology Q2
International Journal of Oncology Q2
Cancer Epidemiology Q2
Translational Lung Cancer Research Q2
Familial Cancer Q2
Compare this journals

Aims and Scope

cancer, cell, cells, breast, human, tumor, expression, inhibition, protein, lung, carcinoma, stem, growth, patients, prostate, kinase, cd, leukemia, inhibits, squamous, signaling, prognostic, inhibitor, antitumor,

FAQS

What is the impact factor of Oncotarget?

In Country of Paypers you can find Impact factor and other metrics to help you decide on a Journal.